Misonix Inc. (NASDAQ: MSON; Stock Twits: $MSON) develops, manufactures and markets ultrasonic medical devices which are used primarily for spine surgery, neurosurgery, general surgery, maxillofacial surgery, cosmetic surgery and surgical wound debridement. The Companys' three largest selling medical device products --- BoneScalpel™, SonicOne® and SonaStar® --- compete in an addressable world market with over $1 billion in annual sales. 

In recent years, Misonix has transitioned from a diversified manufacturer of ultrasonic products into a more targeted in the medical device company with a greater focus on improving growth and financial returns. 

Misonix has a significant number of issued patents and, with considerable know-how and in-house skills, is believed to be one of the few a companies in the world that has the ability to apply ultrasound technology to a broad range of specialty surgical devices.  All R&D, engineering, product development and manufacturing is done at the Misonix headquarters facility in Farmingdale, Long Island, New York.